Type II Diabetes Mellitus - Associated Risk Factor in the Onset and Evolution of Digestive Tract Carcinoma

被引:3
作者
Nitipir, Cornelia [1 ,2 ]
Barbu, Maria Alexandra [2 ]
Orlov, Cristina [2 ]
Stanciu, Adina Elena [3 ]
Popa, Ana Maria [2 ]
Hainarosie, Razvan [1 ]
Pituru, Silviu [1 ]
Arsene, Andreea Letitia [4 ]
Stoian, Anca Pantea [5 ]
机构
[1] Carol Davila Univ Med & Pharm, Bucharest, Romania
[2] Elias Emergency Univ Hosp, Dept Med Oncol, Bucharest, Romania
[3] Prof Dr Al Trestioreanu Inst Oncol, Dept Carcinogenesis & Mol Biol, Bucharest, Romania
[4] Carol Davila Univ, Fac Pharm, Dept Gen & Pharmaceut Microbiol, Bucharest, Romania
[5] Carol Davila Univ Med & Pharm, Dept Hyg, Bucharest, Romania
来源
ROMANIAN BIOTECHNOLOGICAL LETTERS | 2019年 / 24卷 / 01期
关键词
diabetes; digestive cancers; risk factor; inflammatory syndrome; ETHICAL ASPECTS; ENDOCAN; CANCER; HEAD;
D O I
10.25083/rbl/24.1/140.146
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Introduction: The number of digestive cancers cases has alarmingly increased within the past decades up to a current third place ranking in terms of global incidence. The association between type II diabetes mellitus and digestive neoplasms has been on an upward trend lately due to common risk factors as well as to mutually potentiating effects on the evolution of the two conditions. Patients and methods: This clinical study evaluates a group of 34 gastro intestinal cancer patients suffering from type II diabetes mellitus who received treatment in 'Elias University Emergency Hospital', Medical Oncology division, between 2010 and 2016. A number of demographic features specific to the aforementioned group, as well as comorbidities linked to localization, the aggressiveness of primary digestive tumor and the presence of the biological inflammatory syndrome were evaluated. Discussion: Digestive neoplasms associated with type II diabetes mellitus turn out to be more aggressive. The therapy is burdened by potential risks arising from all associated pathologies. Conclusions: A set of clinical and biological data underpin the association between type II diabetes mellitus and digestive neoplasms as being detrimental. Therefore, screening measures for digestive neoplasms in type II diabetes mellitus patients should be carefully respected.
引用
收藏
页码:140 / 146
页数:7
相关论文
共 18 条
  • [1] Arcan O, 2014, ROM BIOTECH LETT, V19, P9763
  • [2] Molecular signatures in biopsy specimens of lung cancer
    Borczuk, AC
    Shah, L
    Pearson, GDN
    Walter, KL
    Wang, LQ
    Austin, JHM
    Friedman, RA
    Powell, CA
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (02) : 167 - 174
  • [3] Identification of a 14 kDa endocan fragment generated by cathepsin G, a novel circulating biomarker in patients with sepsis
    Caires, Nathalie De Freitas
    Legendre, Benjamin
    Parmentier, Erika
    Scherpereel, Arnaud
    Tsicopoulos, Anne
    Mathieu, Daniel
    Lassalle, Philippe
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 78-79 : 45 - 51
  • [4] Cancer Research UK, 2016, PANCR CANC INC STAT
  • [5] Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
    Ferlay, Jacques
    Soerjomataram, Isabelle
    Dikshit, Rajesh
    Eser, Sultan
    Mathers, Colin
    Rebelo, Marise
    Parkin, Donald Maxwell
    Forman, David
    Bray, Freddie
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) : E359 - E386
  • [6] Diabetes and Cancer A consensus report
    Giovannucci, Edward
    Harlan, David M.
    Archer, Michael C.
    Bergenstal, Richard M.
    Gapstur, Susan M.
    Habel, Laurel A.
    Pollak, Michael
    Regensteiner, Judith G.
    Yee, Douglas
    [J]. DIABETES CARE, 2010, 33 (07) : 1674 - 1685
  • [7] Endocan Expression Correlated with Poor Survival in Human Hepatocellular Carcinoma
    Huang, Geng-Wen
    Tao, Yi-Ming
    Ding, Xiang
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (02) : 389 - 394
  • [8] International Diabetes Federation, 2017, AB DIAB
  • [9] Obesity and Type 2 Diabetes are Associated with an Increased Risk of Developing Cancer and a Worse Prognosis; Epidemiological and Mechanistic Evidence
    LeRoith, D.
    Novosyadlyy, R.
    Gallagher, E. J.
    Lann, D.
    Vijayakumar, A.
    Yakar, S.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 : S4 - S6
  • [10] Antidiabetic Therapies Affect Risk of Pancreatic Cancer
    Li, Donghui
    Yeung, Sai-Ching J.
    Hassan, Manal M.
    Konopleva, Marina
    Abbruzzese, James L.
    [J]. GASTROENTEROLOGY, 2009, 137 (02) : 482 - 488